BERLIN & CARSON CITY, Nev.--(BUSINESS WIRE)--MagForce AG (Frankfurt, Entry Standard, XETRA: MF6, ISIN: DE000A0HGQF5), a leading medical device company in the field of nanomedicine focused on oncology, today announced that the Center for Integrated Oncology at Cologne University Hospital, headed by Prof. Dr. med. Roland Goldbrunner, has initiated NanoTherm(TM) therapy in the commercial setting for the treatment of brain cancers in addition to the ongoing post-marketing study.
Help employers find you! Check out all the jobs and post your resume.
